SEC Form 4 · accession 0000874015-15-000012
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah Boyce
Officer — Chief Business Officer
Period of report
Jan 1, 2015
Accepted (ET)
Jan 5, 2015 · 8:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $61.74 | Jan 1, 2015 | A | 52,500 | A | Jan 1, 2016 | Dec 31, 2021 | Common Stock | 52,500 | 52,500 | D |
Explanation of responses
- F1Grant of 1/1/2015 to reporting person of stock options under the Isis Pharmacueticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/1/2016. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 13,125 shares per year. The option was exercisable as to 0 on 1/1/2015.